Furthermore, Calebin A has a significant anti-inflammatory potential and it down-regulates multicellular TME-induced tumor malignancy by specific targeting the p65-NF-κB signaling pathway, leading to suppressed proliferation and induction of apoptosis. This evidence concerns the gene NFKB1 and neoplasm.